Results
|
|
1.
|
Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?. MedStar authors:
- Alintah, Princess
- Chitalia, Ami
- Dilawari, Asma
- Gallagher, Christopher
- Tiwari, Shruti
Year: 2021
Citation: - Oncologist. 26(4):292-e548, 2021 04.
Institution:
- MedStar Health Research Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Adams-Campbell L, Alintah P, Chitalia A, Dash C, Dilawari A, Gallagher C, Paxman R, Tiwari S
|
|
|
2.
|
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors:
- Blackburn, Matthew J
- Chitalia, Ami
- Dilawari, Asma
- Gallagher, Christopher
- Lynce, Filipa
- Mohebtash, Mahsa
- Tiwari, Shruti R
Year: 2021
Citation: - Cancer. 127(19):3622-3630, 2021 10 01.
Institution:
- MedStar Franklin Square Cancer Center at Loch Raven Campus
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Hematology & Oncology Fellowship
- Hematology and Oncology
Medline publication type:
All authors: - Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R
|
|
|
3.
|
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. MedStar authors:
- Chitalia, Ami
- Gallagher, Christopher
- Schlam, Ilana
- Swain, Sandra M
- Tiwari, Shruti
Year: 2023
Citation: - MedRxiv : the Preprint Server for Health Sciences. 2023 Dec 04
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C
|
|
|
4.
|
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. MedStar authors:
- Chitalia, Ami
- Gallagher, Christopher
- Schlam, Ilana
- Swain, Sandra M
- Tiwari, Shruti
Year: 2024
Citation: - Nature communications . 15(1):2691, 2024 Mar 27.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
All authors: - Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C
|
